Moyo logo

Families

Theranos

1 investigation · 2 maps · 248 claims · Last updated 2d ago

Copy page link
LinkedInXFacebookWhatsAppEmail
Theranos (Markdown)Theranos - Elizabeth Holmes Hero Arc Fork (Markdown)

Overview

Theranos: 1 public investigation and 248 claims.

Map overviews

Sort

View

  • 5
    Theranos

    submitted 2 days ago by @david 149

    123 claims
    +3
    OverviewThis map focuses on the operational, clinical, and financial mechanics of Theranos's fraud. It examines lab irregularities, specific assay failures, the scope of voided tests in Arizona, and Walgreens partnership agreements. The map argues through detailed laboratory records, financial figures, and trial testimony.
  • 5
    Theranos - Elizabeth Holmes Hero Arc Fork

    submitted Oct 22, 2026 by @nineDan 203

    125 claims
    +3

    Forked from Theranos

    OverviewThis map investigates the post-conviction legal proceedings and Elizabeth Holmes's personal defense trajectory. It details judicial deliberations over sentencing guideline calculations, victim hardship thresholds, and post-trial prison sentence reductions. Its arguments center on case law interpretations, jury verdicts, and Holmes's media efforts to reshape public perception.

Last generated Oct 25, 2026, 6:55 PM by a member

More information

Compared Oct 25, 2026, 6:55 PM

Maps

Open map

Comparing maps…

Themes across the family

A broad read of every map in this family: the themes that run through them and how each map treats them. Structured scans give a more targeted side-by-side.

  • Dual Lab Operations and Commercial Analyzer Deception

    2 of 2 maps

    Both maps highlight that Theranos maintained a fraudulent front by demonstrating proprietary Edison hardware while secretly running patient samples and proficiency checks on commercial machines.

    M1Theranos

    Emphasizes the clandestine acquisition of Siemens ADVIA analyzers and running separate lab workflows to deceive partners and pass certification.

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    Shows how the secret use of third-party machines formed the basis of regulatory scrutiny and criminal fraud findings.

  • Quality Control Failures and Result Invalidation

    2 of 2 maps

    The maps detail systemic quality control failures, intentional deletion of outlier data, and the subsequent mass voiding of tens of thousands of diagnostic results.

    M1Theranos

    Focuses on the operational scale of invalidations, including specific assay failures, deleted outliers, and hundreds of thousands of impacted Arizona results.

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    Connects quality control failures and two-year retroactive test voids to regulatory sanctions under CLIA.

  • Legal, Sentencing, and Regulatory Accountability

    2 of 2 maps

    Both maps track the severe regulatory and criminal repercussions faced by Theranos leadership, from CMS bans and HHS exclusions to federal prison sentences.

    M1Theranos

    Documents administrative exclusions by HHS and victim impact evidence presented in federal sentencing.

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    Examines detailed judicial findings on sentencing guidelines, sentence reductions, and disparate trial outcomes between Holmes and Balwani.

  • Corporate Mythmaking and Narrative Control

    2 of 2 maps

    The family explores how Elizabeth Holmes curated deceptive corporate artifacts and continued attempting to rehabilitate her public narrative post-trial.

    M1Theranos

    Concentrates on document alterations and the fabrication of third-party endorsements from pharmaceutical companies.

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    Analyzes Holmes's ongoing media strategy and documentary participation to contest the narrative and clear her name.

  • Theranos operated parallel laboratory environments, using commercial analyzers behind the scenes while showcasing proprietary technology for investor demonstrations.

    M1Theranos

    C0203Secret Siemens dealKnown correct

    Theranos purchased commercial Siemens ADVIA analyzers through a secret subsidiary to avoid suspicion from Siemens because their own technology failed.

    Source-linkedHigh significanceGemini

    M1Theranos

    C0226Theranos lab systems separateKnown correct

    Theranos operated two separate lab systems: one for demonstrations to investors/partners using the Edison device, and another for actual patient results using commercial analyzers.

    Source-linkedHigh significanceClaude, Gemini

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    C0203Secret Siemens dealKnown correct

    Source-linkedHigh significanceGemini

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    C0226Dual lab systems usedKnown correct

    Source-linkedHigh significanceClaude, Gemini

  • Supervisory practices at Theranos routinely involved discarding quality control outliers to force failing test runs into passing thresholds.

    M1Theranos

    C0014Outlier data ignoredInvestigate with AI

    Erika Cheung reported that Theranos supervisors instructed staff to delete or disregard outlier quality control data points to make runs pass.

    InferredHigh significanceClaude

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    C0093Data deleted from QC runs

    The deletion of data points from QC runs on Edison devices was done so that the remaining average would pass internal thresholds.

    InferredHigh significanceGrok

  • Proficiency testing samples mandated by federal regulators were routed exclusively to third-party commercial machines to maintain laboratory certification.

    M1Theranos

    C0210Lab staff orderedKnown correct

    Sunny Balwani ordered lab staff to run federal proficiency testing samples exclusively on third-party commercial analyzers rather than the Edison to maintain CLIA lab certification.

    Source-linkedHigh significanceGemini

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    C0210Balwani orders third-party analyzersKnown correct

    Source-linkedHigh significanceGemini

Build on the map here to find more

Disagreement0

No opposing points yet.

Build on the map here to find more

  • Theranos provides comprehensive quantitative accounting of consumer test orders, void rates, and restitution specifics from the Arizona regulatory action.

    M1Theranos

    C0079Voided test results high

    Approximately 834,233 (exactly 10.6%) of the 7,862,146 test results provided by Theranos to Arizona consumers between 2013 and 2016 were ultimately voided or corrected.

    InferredHigh significanceGrok

  • Theranos - Elizabeth Holmes Hero Arc Fork focuses intensely on federal sentencing jurisprudence regarding zero-point offenders and the legal definition of substantial financial hardship.

    M2Theranos - Elizabeth Holmes Hero Arc Fork

    C0039No victim experienced hardship

    Judge Davila's conclusion was that the record did not establish any identified victim experienced the individualized “substantial financial hardship” required to disqualify Holmes under §4C1.1(a)(6).

    InferredHigh significanceChatGPT

Shared open questions0

No shared open questions.

Discussion

Tag a map with @(M1), a claim on that map with @(M1/C0001), a generating prompt with @(M1/P…), or a person with @username. Type @ to search.

No comments yet.